CUTAIA, ORNELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.778
EU - Europa 1.255
AS - Asia 632
SA - Sud America 109
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 32
OC - Oceania 1
Totale 3.873
Nazione #
US - Stati Uniti d'America 1.742
RU - Federazione Russa 343
SG - Singapore 252
IT - Italia 248
IE - Irlanda 204
GB - Regno Unito 157
CN - Cina 155
BR - Brasile 88
VN - Vietnam 87
SE - Svezia 65
FR - Francia 53
DE - Germania 51
HK - Hong Kong 50
UA - Ucraina 42
FI - Finlandia 25
ES - Italia 23
ZA - Sudafrica 20
IN - India 19
CA - Canada 18
BD - Bangladesh 14
MX - Messico 13
CO - Colombia 8
EC - Ecuador 8
IQ - Iraq 8
KR - Corea 8
PL - Polonia 8
AT - Austria 7
JP - Giappone 6
TR - Turchia 6
LT - Lituania 5
NL - Olanda 5
CH - Svizzera 4
BE - Belgio 3
DZ - Algeria 3
ID - Indonesia 3
PH - Filippine 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MA - Marocco 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.807
Città #
Dublin 203
Fairfield 198
Ashburn 163
Singapore 141
Southend 123
San Jose 113
Dallas 109
Moscow 97
Woodbridge 92
Santa Clara 90
Cambridge 84
Seattle 76
Houston 65
Wilmington 65
Beijing 59
Hong Kong 49
Milan 46
New York 46
Siena 40
Jacksonville 36
Chandler 33
Ann Arbor 30
Princeton 28
Ho Chi Minh City 27
Los Angeles 26
Council Bluffs 24
The Dalles 24
Shanghai 21
Johannesburg 19
Lauterbourg 18
San Diego 18
Rome 17
Helsinki 15
Munich 15
Málaga 15
San Mateo 14
Hanoi 12
Denver 11
Dong Ket 11
Hefei 11
Buffalo 9
Palermo 9
Stockholm 9
Brooklyn 8
Florence 8
Seoul 8
São Paulo 8
Boston 6
Columbus 6
Dearborn 6
Orem 6
Piscataway 6
San Francisco 6
Tokyo 6
Turku 6
Warsaw 6
Boardman 5
Chicago 5
Labico 5
Montreal 5
Nanjing 5
Nuremberg 5
Phoenix 5
Poplar 5
San Giovanni Valdarno 5
Atlanta 4
Avon 4
Barnet 4
Charlotte 4
Düsseldorf 4
Fremont 4
Guayaquil 4
Hounslow 4
Medellín 4
Redondo Beach 4
Redwood City 4
Venezia 4
Zurich 4
Araxá 3
Asciano 3
Bogotá 3
Borgo San Lorenzo 3
Brussels 3
Chennai 3
Da Nang 3
Empoli 3
Figino 3
Frankfurt am Main 3
Genoa 3
Hải Dương 3
Istanbul 3
Lavis 3
London 3
New Delhi 3
Ninh Bình 3
Querétaro 3
Secaucus 3
Toronto 3
Trieste 3
Turin 3
Totale 2.560
Nome #
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 340
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: Results of a phase II study 336
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy 276
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 266
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 252
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 244
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy 241
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015 221
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 214
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 209
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications 193
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy? 180
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 165
ICOS expression as immunologic marker in immune activating monoclonal antibodies 155
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 154
“Cancer Bio-Immunotherapy in Siena”: Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9–11, 2014 152
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 145
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: An open-label, single-arm, phase 2 study 130
Totale 3.873
Categoria #
all - tutte 12.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 0 0 0 6 9 11 13 9 6 25 36 41
2022/2023231 19 13 36 18 8 42 10 16 24 16 19 10
2023/2024329 16 8 35 15 11 94 111 5 5 5 14 10
2024/2025497 15 19 57 18 72 36 15 27 62 22 43 111
2025/20261.391 88 147 79 202 390 65 154 49 15 57 43 102
2026/2027193 53 46 61 33 0 0 0 0 0 0 0 0
Totale 3.873